QGEN
Qiagen N.V.
NYSE · Healthcare · Medical - Diagnostics & Research · NL
$43.55
−0.71%Institutional positioning
13F filings over the trailing two quarters
New 196Increased 209Reduced 248Sold out 76
| Filer | Action | Shares | Filed |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 14,364,303 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 12,406,763 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 11,354,379 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | New Position | 8,429,334 | May 15, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | Increased | 6,648,681 | Aug 4, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 6,209,904 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 6,106,275 | May 15, 2026 |
| BlackRock, Inc. | Increased | 5,905,678 | Aug 7, 2026 |
| DEUTSCHE BANK AG\ | Reduced | 5,601,957 | May 6, 2026 |
| BLACKROCK, INC. | Reduced | 5,250,461 | May 13, 2026 |
| MORGAN STANLEY | Increased | 5,042,391 | Aug 13, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 4,903,674 | Aug 14, 2026 |
| AMUNDI | Increased | 4,757,681 | May 18, 2026 |
| EARNEST PARTNERS LLC | Increased | 4,573,455 | Aug 13, 2026 |
| NORGES BANK | New Position | 4,325,135 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings